ANIP
ANI Pharmaceuticals Inc
NASDAQ: ANIP · HEALTHCARE · DRUG MANUFACTURERS - SPECIALTY & GENERIC
$77.97
-0.68% today
Updated 2026-04-29
Market cap
$1.77B
P/E ratio
23.48
P/S ratio
2.01x
EPS (TTM)
$3.32
Dividend yield
—
52W range
$57 – $100
Volume
0.4M
ANI Pharmaceuticals Inc (ANIP) Earnings
Quarterly earnings history, analyst estimates, and stock price reaction.
EPS beat streak
6 of 8
Last 8 quarters
Avg EPS surprise
+39.0%
Last 4 quarters
Revenue YoY growth
+29.6%
Most recent quarter
EPS YoY growth
+523.6%
Most recent quarter
Earnings surprise history (last 12 quarters)
Beat estimate Missed estimate
Quarterly EPS and revenue trend
Quarterly revenue EPS (diluted)
How the stock reacts to earnings
Avg 1-day reaction
+6.1%
Last 3 reports
Positive reaction rate
33%
1 of 3 quarters
Largest single-day move
+23.0%
2025-08-08
| Report date | EPS actual | Surprise | Close before | Close after | 1-day reaction |
|---|---|---|---|---|---|
| 2026-02-26 | $2.33 | +14.2% | $76.30 | $73.90 | -3.1% |
| 2025-11-07 | $2.04 | +15.9% | $90.23 | $88.93 | -1.4% |
| 2025-08-08 | $0.36 | -74.3% | $69.01 | $84.88 | +23.0% |
Quarterly earnings history
| Fiscal quarter ending | EPS estimate | EPS actual | Surprise | Revenue | YoY revenue |
|---|---|---|---|---|---|
| 2025-12-31 | $2.04 | $2.33 | +14.2% | $247.06M | +29.6% |
| 2025-09-30 | $1.76 | $2.04 | +15.9% | $227.81M | +53.6% |
| 2025-06-30 | $1.40 | $0.36 | -74.3% | $211.37M | +53.1% |
| 2025-03-31 | $-0.07 | $0.69 | +1161.5% | $197.12M | +43.4% |
| 2024-12-31 | $0.29 | $-0.55 | -287.5% | $190.57M | +44.8% |
| 2024-09-30 | $1.09 | $1.34 | +22.9% | $148.33M | +12.5% |
| 2024-06-30 | $0.95 | $1.02 | +7.4% | $138.04M | +18.4% |
| 2024-03-31 | $1.00 | $1.21 | +21.0% | $137.43M | +28.7% |
| 2023-12-31 | $0.86 | $1.00 | +16.3% | $131.65M | — |
| 2023-09-30 | $0.84 | $1.27 | +51.2% | $131.83M | — |
| 2023-06-30 | $0.68 | $1.28 | +88.2% | $116.55M | — |
| 2023-03-31 | $0.35 | $1.17 | +234.3% | $106.79M | — |
Frequently asked questions
Has ANI Pharmaceuticals Inc beaten earnings estimates?
ANI Pharmaceuticals Inc has beaten Wall Street EPS estimates in 6 of its last 8 quarterly reports, with an average EPS surprise of +39.0% over the last 4 quarters.
How does ANIP stock react to earnings?
ANIP stock has moved an average of +6.1% in the trading day following earnings over its last 3 reports, with positive reactions in 33% of those quarters.
What is ANI Pharmaceuticals Inc's revenue growth rate?
ANI Pharmaceuticals Inc reported year-over-year revenue growth of +29.6% in its most recent quarter, with EPS growing +523.6% year-over-year.